AU2007284665A1 - High speed swelling, pressure exerting hemostatic device - Google Patents
High speed swelling, pressure exerting hemostatic device Download PDFInfo
- Publication number
- AU2007284665A1 AU2007284665A1 AU2007284665A AU2007284665A AU2007284665A1 AU 2007284665 A1 AU2007284665 A1 AU 2007284665A1 AU 2007284665 A AU2007284665 A AU 2007284665A AU 2007284665 A AU2007284665 A AU 2007284665A AU 2007284665 A1 AU2007284665 A1 AU 2007284665A1
- Authority
- AU
- Australia
- Prior art keywords
- polymer particles
- hemostatic
- membrane
- porous membrane
- enclosure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000002439 hemostatic effect Effects 0.000 title claims description 130
- 230000008961 swelling Effects 0.000 title description 54
- 229920000642 polymer Polymers 0.000 claims description 124
- 239000002245 particle Substances 0.000 claims description 107
- 239000012528 membrane Substances 0.000 claims description 99
- 239000012530 fluid Substances 0.000 claims description 84
- 239000008280 blood Substances 0.000 claims description 83
- 210000004369 blood Anatomy 0.000 claims description 82
- 239000000463 material Substances 0.000 claims description 51
- 239000000835 fiber Substances 0.000 claims description 40
- 238000000034 method Methods 0.000 claims description 40
- 239000011148 porous material Substances 0.000 claims description 18
- 230000002745 absorbent Effects 0.000 claims description 15
- 239000002250 absorbent Substances 0.000 claims description 15
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 claims description 13
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 claims description 13
- 229920002334 Spandex Polymers 0.000 claims description 9
- -1 polyethylene terephthalate Polymers 0.000 claims description 9
- 239000004759 spandex Substances 0.000 claims description 9
- 239000000853 adhesive Substances 0.000 claims description 8
- 230000001070 adhesive effect Effects 0.000 claims description 8
- 239000011324 bead Substances 0.000 claims description 7
- 239000013013 elastic material Substances 0.000 claims description 7
- 239000004094 surface-active agent Substances 0.000 claims description 7
- 229920000058 polyacrylate Polymers 0.000 claims description 6
- 239000004743 Polypropylene Substances 0.000 claims description 5
- 229920001155 polypropylene Polymers 0.000 claims description 5
- 125000000129 anionic group Chemical group 0.000 claims description 4
- 229920001778 nylon Polymers 0.000 claims description 4
- 239000004677 Nylon Substances 0.000 claims description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- 239000011734 sodium Substances 0.000 claims description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 claims 2
- 239000005020 polyethylene terephthalate Substances 0.000 claims 2
- 239000012982 microporous membrane Substances 0.000 claims 1
- 208000027418 Wounds and injury Diseases 0.000 description 89
- 206010052428 Wound Diseases 0.000 description 69
- 239000002874 hemostatic agent Substances 0.000 description 41
- 238000010521 absorption reaction Methods 0.000 description 32
- 238000011282 treatment Methods 0.000 description 32
- 208000032843 Hemorrhage Diseases 0.000 description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 28
- 208000034158 bleeding Diseases 0.000 description 26
- 231100000319 bleeding Toxicity 0.000 description 26
- 230000000740 bleeding effect Effects 0.000 description 26
- 238000012360 testing method Methods 0.000 description 23
- 208000014674 injury Diseases 0.000 description 22
- 230000006378 damage Effects 0.000 description 21
- 229920000247 superabsorbent polymer Polymers 0.000 description 19
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 18
- 239000000203 mixture Substances 0.000 description 14
- 241001465754 Metazoa Species 0.000 description 12
- 239000000499 gel Substances 0.000 description 12
- 241000282898 Sus scrofa Species 0.000 description 11
- 238000002474 experimental method Methods 0.000 description 11
- 230000004083 survival effect Effects 0.000 description 10
- 210000004013 groin Anatomy 0.000 description 9
- 238000007789 sealing Methods 0.000 description 9
- 229910001415 sodium ion Inorganic materials 0.000 description 9
- 150000003839 salts Chemical class 0.000 description 8
- 230000015271 coagulation Effects 0.000 description 7
- 238000005345 coagulation Methods 0.000 description 7
- 238000002203 pretreatment Methods 0.000 description 7
- 206010053567 Coagulopathies Diseases 0.000 description 6
- 230000004872 arterial blood pressure Effects 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- 230000036772 blood pressure Effects 0.000 description 6
- 230000035602 clotting Effects 0.000 description 6
- 230000006835 compression Effects 0.000 description 6
- 238000007906 compression Methods 0.000 description 6
- 230000034994 death Effects 0.000 description 6
- 231100000517 death Toxicity 0.000 description 6
- 238000013459 approach Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 229920002959 polymer blend Polymers 0.000 description 5
- 239000002861 polymer material Substances 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 239000004583 superabsorbent polymers (SAPs) Substances 0.000 description 5
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 238000010276 construction Methods 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 210000003414 extremity Anatomy 0.000 description 4
- 239000004744 fabric Substances 0.000 description 4
- 210000001105 femoral artery Anatomy 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 231100000518 lethal Toxicity 0.000 description 4
- 230000001665 lethal effect Effects 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 230000036961 partial effect Effects 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 230000000472 traumatic effect Effects 0.000 description 4
- 210000001367 artery Anatomy 0.000 description 3
- 239000007767 bonding agent Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000008367 deionised water Substances 0.000 description 3
- 229910021641 deionized water Inorganic materials 0.000 description 3
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 239000000017 hydrogel Substances 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 230000003204 osmotic effect Effects 0.000 description 3
- 230000002522 swelling effect Effects 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 2
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241000282887 Suidae Species 0.000 description 2
- 229910021536 Zeolite Inorganic materials 0.000 description 2
- 229940030225 antihemorrhagics Drugs 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 230000002596 correlated effect Effects 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 210000003191 femoral vein Anatomy 0.000 description 2
- 239000012765 fibrous filler Substances 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 238000002637 fluid replacement therapy Methods 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- 230000001788 irregular Effects 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 210000003041 ligament Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000010534 mechanism of action Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 230000002028 premature Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 239000005060 rubber Substances 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 210000004872 soft tissue Anatomy 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- 210000000689 upper leg Anatomy 0.000 description 2
- 239000010457 zeolite Substances 0.000 description 2
- GASMGDMKGYYAHY-UHFFFAOYSA-N 2-methylidenehexanamide Chemical class CCCCC(=C)C(N)=O GASMGDMKGYYAHY-UHFFFAOYSA-N 0.000 description 1
- QPMZMJZDPOJMLC-UHFFFAOYSA-N 3-methyl-2-methylidenebutanamide Chemical class CC(C)C(=C)C(N)=O QPMZMJZDPOJMLC-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010015719 Exsanguination Diseases 0.000 description 1
- 208000009087 False Aneurysm Diseases 0.000 description 1
- 206010018852 Haematoma Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 239000005062 Polybutadiene Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 206010048975 Vascular pseudoaneurysm Diseases 0.000 description 1
- 206010047139 Vasoconstriction Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 239000011358 absorbing material Substances 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 229940046545 animal allergen extract Drugs 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229910052729 chemical element Inorganic materials 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000002586 coronary angiography Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000035487 diastolic blood pressure Effects 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229940035564 duration Drugs 0.000 description 1
- 230000009881 electrostatic interaction Effects 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000002697 interventional radiology Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000002350 laparotomy Methods 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 229920002857 polybutadiene Polymers 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001195 polyisoprene Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 235000021251 pulses Nutrition 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 238000009958 sewing Methods 0.000 description 1
- 238000005029 sieve analysis Methods 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000035488 systolic blood pressure Effects 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- KKEYFWRCBNTPAC-UHFFFAOYSA-L terephthalate(2-) Chemical compound [O-]C(=O)C1=CC=C(C([O-])=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-L 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000025033 vasoconstriction Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 239000002759 woven fabric Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/01—Non-adhesive bandages or dressings
- A61F13/01008—Non-adhesive bandages or dressings characterised by the material
- A61F13/01017—Non-adhesive bandages or dressings characterised by the material synthetic, e.g. polymer based
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/00051—Accessories for dressings
- A61F13/00063—Accessories for dressings comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/01—Non-adhesive bandages or dressings
- A61F13/01021—Non-adhesive bandages or dressings characterised by the structure of the dressing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/01—Non-adhesive bandages or dressings
- A61F13/01034—Non-adhesive bandages or dressings characterised by a property
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/01—Non-adhesive bandages or dressings
- A61F13/01034—Non-adhesive bandages or dressings characterised by a property
- A61F13/01038—Flexibility, stretchability or elasticity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/60—Liquid-swellable gel-forming materials, e.g. super-absorbents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00365—Plasters use
- A61F2013/00463—Plasters use haemostatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00365—Plasters use
- A61F2013/00463—Plasters use haemostatic
- A61F2013/00472—Plasters use haemostatic with chemical means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00365—Plasters use
- A61F2013/0054—Plasters use for deep wounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00655—Plasters adhesive
- A61F2013/00659—Plasters adhesive polymeric base
- A61F2013/00663—Plasters adhesive polymeric base acrylic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00655—Plasters adhesive
- A61F2013/00685—Plasters adhesive soluble in liquid, e.g. of particular pH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/04—Materials for stopping bleeding
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Materials Engineering (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US83739906P | 2006-08-11 | 2006-08-11 | |
| US60/837,399 | 2006-08-11 | ||
| PCT/US2007/017753 WO2008021212A2 (en) | 2006-08-11 | 2007-08-10 | High speed swelling, pressure exerting hemostatic device |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2007284665A1 true AU2007284665A1 (en) | 2008-02-21 |
Family
ID=38667143
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2007284665A Abandoned AU2007284665A1 (en) | 2006-08-11 | 2007-08-10 | High speed swelling, pressure exerting hemostatic device |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US7838716B2 (enExample) |
| EP (1) | EP2063920A2 (enExample) |
| JP (1) | JP2010500116A (enExample) |
| AU (1) | AU2007284665A1 (enExample) |
| CA (1) | CA2695526A1 (enExample) |
| WO (1) | WO2008021212A2 (enExample) |
| ZA (1) | ZA200901707B (enExample) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0224986D0 (en) | 2002-10-28 | 2002-12-04 | Smith & Nephew | Apparatus |
| GB0325129D0 (en) | 2003-10-28 | 2003-12-03 | Smith & Nephew | Apparatus in situ |
| US10058642B2 (en) | 2004-04-05 | 2018-08-28 | Bluesky Medical Group Incorporated | Reduced pressure treatment system |
| EP3254650B1 (en) | 2007-11-21 | 2020-01-08 | Smith & Nephew plc | Wound dressing |
| JP5613566B2 (ja) | 2007-11-21 | 2014-10-22 | スミス アンド ネフュー ピーエルシーＳｍｉｔｈ ＆ Ｎｅｐｈｅｗ Ｐｕｂｌｉｃ Ｌｉｍｉｔｅｄ Ｃｏｍｐａｎｙ | 創傷被覆材 |
| GB0722820D0 (en) | 2007-11-21 | 2008-01-02 | Smith & Nephew | Vacuum assisted wound dressing |
| US8828358B2 (en) * | 2008-03-11 | 2014-09-09 | Materials Modifications, Inc. | In situ formation of an artificial blockage to control bleeding by polymer expansion with hydrogen peroxide |
| US8852558B2 (en) * | 2008-03-11 | 2014-10-07 | Materials Modification, Inc. | In situ formation of an artificial blockage to control bleeding by polymer expansion with hydrogen peroxide and platinum catalyst |
| AU2009262879B2 (en) * | 2008-05-30 | 2013-05-02 | Solventum Intellectual Properties Company | Dressing assemblies for wound treatment using reduced pressure |
| CA2725569C (en) | 2008-05-30 | 2014-11-25 | Kci Licensing, Inc. | Reduced-pressure, linear wound closing bolsters and systems |
| GB2468905B (en) * | 2009-03-27 | 2013-12-11 | Brightwake Ltd | Wound packing material |
| US20100280428A1 (en) * | 2009-04-25 | 2010-11-04 | Widgerow Alan D | Medical device for shrinking open wounds |
| AU2010246025B2 (en) * | 2009-05-04 | 2015-11-12 | Oregon Biomedical Engineering Institute, Inc. | Hemorrhage control devices and methods |
| EP2461863B1 (en) * | 2009-08-05 | 2016-07-27 | Covidien LP | Surgical wound dressing incorporating connected hydrogel beads having an embedded electrode therein |
| GB0922258D0 (en) * | 2009-12-21 | 2010-02-03 | Smith & Nephew | Device for administration to a wound cavity |
| US20110237994A1 (en) * | 2010-03-25 | 2011-09-29 | Combat Medical Systems, Llc | Void-filling wound dressing |
| US9061095B2 (en) | 2010-04-27 | 2015-06-23 | Smith & Nephew Plc | Wound dressing and method of use |
| US9623223B2 (en) | 2011-02-16 | 2017-04-18 | Revmedx, Inc. | Wound dressings comprising a plurality of liquid-expandable articles |
| CA2827486A1 (en) | 2011-02-16 | 2012-08-23 | Andrew BAROFSKY | Wound stasis dressing for large surface wounds |
| WO2013025685A1 (en) | 2011-08-14 | 2013-02-21 | Materials Modification, Inc. | Method and composition for in situ formation of an artificial blockage to control blood loss |
| US8993831B2 (en) * | 2011-11-01 | 2015-03-31 | Arsenal Medical, Inc. | Foam and delivery system for treatment of postpartum hemorrhage |
| US20160175157A1 (en) * | 2014-12-22 | 2016-06-23 | Terence W. Kolb | Impregnable and Expanding Wound Packing Article |
| EP3248578A1 (en) * | 2016-05-24 | 2017-11-29 | Biocer-Entwicklungs-GmbH | Unit for hemostasis and arrangement containing the same |
| CN107252335B (zh) * | 2017-06-28 | 2023-02-28 | 王洛 | 止血装置及用于推送该止血装置的注射器 |
| WO2019038767A1 (en) * | 2017-08-24 | 2019-02-28 | Shlomo Nevo | REFRIGERANT PACK SYSTEM |
| GB202310268D0 (en) * | 2023-07-05 | 2023-08-16 | Smith & Nephew | Negative pressure wound therapy devices and methods utilizing a wound filler |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4293609A (en) * | 1979-07-09 | 1981-10-06 | The Dow Chemical Company | Flexible absorbent laminates |
| DE3464326D1 (en) * | 1983-04-06 | 1987-07-30 | Smith & Nephew Ass | Dressing |
| US4957795A (en) * | 1988-05-13 | 1990-09-18 | Minnesota Mining And Manufacturing Company | Absorbent elastomeric wound dressing |
| IL92966A (en) * | 1989-01-12 | 1995-07-31 | Pfizer | Dispensing devices powered by hydrogel |
| US5824004A (en) * | 1990-06-18 | 1998-10-20 | The Procter & Gamble Company | Stretchable absorbent articles |
| DE4021353A1 (de) * | 1990-07-05 | 1992-01-09 | Rotecno Ag | Medizinisches operations-abdecktuch |
| US5998032A (en) * | 1992-08-17 | 1999-12-07 | Weyerhaeuser Company | Method and compositions for enhancing blood absorbence by superabsorbent materials |
| GB2272645B8 (en) * | 1992-11-23 | 2010-02-10 | Johnson & Johnson Medical | Wound dressing |
| GB2324732B (en) * | 1997-05-02 | 2001-09-26 | Johnson & Johnson Medical | Absorbent wound dressings |
| US6660301B1 (en) * | 1998-03-06 | 2003-12-09 | Biosphere Medical, Inc. | Injectable microspheres for dermal augmentation and tissue bulking |
| US6627785B1 (en) * | 2000-02-29 | 2003-09-30 | Virginia Commwealth University | Wound dressings with protease-lowering activity |
| US20070009586A1 (en) * | 2000-02-29 | 2007-01-11 | Cohen Kelman I | Wound dressings containing complexes of transition metals and alginate for elastase sequestering |
| JP2004508137A (ja) | 2000-09-12 | 2004-03-18 | ヴァージニア コモンウェルス ユニバーシティ | 高圧出血に対する処置 |
| US20040013715A1 (en) * | 2001-09-12 | 2004-01-22 | Gary Wnek | Treatment for high pressure bleeding |
| DE60235087D1 (de) * | 2001-05-22 | 2010-03-04 | Uni Charm Corp | Interlabial-polster |
| US8741335B2 (en) * | 2002-06-14 | 2014-06-03 | Hemcon Medical Technologies, Inc. | Hemostatic compositions, assemblies, systems, and methods employing particulate hemostatic agents formed from hydrophilic polymer foam such as Chitosan |
| US7279177B2 (en) * | 2002-06-28 | 2007-10-09 | Ethicon, Inc. | Hemostatic wound dressings and methods of making same |
| US7495146B2 (en) * | 2004-07-15 | 2009-02-24 | Vivo Ltd. Partnership | Wound dressing |
| JP2008531498A (ja) | 2005-02-15 | 2008-08-14 | バージニア コモンウェルス ユニバーシティ | 緊急止血ならびに急性創傷および慢性潰瘍の治療のための鉱物技術（ｍｔ） |
-
2007
- 2007-08-10 AU AU2007284665A patent/AU2007284665A1/en not_active Abandoned
- 2007-08-10 CA CA2695526A patent/CA2695526A1/en not_active Abandoned
- 2007-08-10 JP JP2009523851A patent/JP2010500116A/ja not_active Withdrawn
- 2007-08-10 ZA ZA200901707A patent/ZA200901707B/xx unknown
- 2007-08-10 WO PCT/US2007/017753 patent/WO2008021212A2/en not_active Ceased
- 2007-08-10 US US11/891,660 patent/US7838716B2/en not_active Expired - Fee Related
- 2007-08-10 EP EP07811231A patent/EP2063920A2/en not_active Withdrawn
-
2010
- 2010-11-22 US US12/952,037 patent/US8395010B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO2008021212A3 (en) | 2008-10-02 |
| WO2008021212A2 (en) | 2008-02-21 |
| EP2063920A2 (en) | 2009-06-03 |
| ZA200901707B (en) | 2010-06-30 |
| US20110270300A1 (en) | 2011-11-03 |
| CA2695526A1 (en) | 2008-02-21 |
| US20080071207A1 (en) | 2008-03-20 |
| US7838716B2 (en) | 2010-11-23 |
| JP2010500116A (ja) | 2010-01-07 |
| US8395010B2 (en) | 2013-03-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8395010B2 (en) | High speed swelling, pressure exerting hemostatic device | |
| Chan et al. | PolySTAT-modified chitosan gauzes for improved hemostasis in external hemorrhage | |
| RU2497490C2 (ru) | Заживляющая раневая повязка, снижающая температуру | |
| JP4812630B2 (ja) | キトサンのような親水性ポリマースポンジ構造体から形成される、組織被覆用のアセンブリ、システムおよび方法 | |
| KR100953465B1 (ko) | 상처 드레싱과 생명을 위협하는 심각한 출혈을 조절하는방법 | |
| Arnaud et al. | Comparison of 10 hemostatic dressings in a groin transection model in swine | |
| KR101148248B1 (ko) | 생명을 위협하는 심한 출혈을 억제하기 위한 상처용 드레싱및 방법 | |
| AU2002312493A1 (en) | Wound dressing and method for controlling severe, life-threatening bleeding | |
| KR20070033948A (ko) | 생명을 위협하는 심한 출혈을 억제하기 위한 상처용 드레싱및 방법 | |
| WO2010102283A2 (en) | Hemostatic agent composition, delivery system and method | |
| CN107007867A (zh) | 止血材料 | |
| JP2018515308A (ja) | 創傷被覆材 | |
| BRPI1003642A2 (pt) | bandagem adesiva acolchoada | |
| GB2525494A (en) | Wound dressing | |
| AU2022287287A1 (en) | Antimicrobial wound dressing |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK4 | Application lapsed section 142(2)(d) - no continuation fee paid for the application |